Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SCFD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GOSR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNRPB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ROCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSANTD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101930404 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTP4A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM69 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GKAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAPPC6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOCS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIDO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCT6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on